Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Harvard Business School
Chubb
Boehringer Ingelheim
Baxter
Cantor Fitzgerald
McKesson
Farmers Insurance
Federal Trade Commission

Generated: December 10, 2018

DrugPatentWatch Database Preview

Drug Price Trends for OSELTAMIVIR

« Back to Dashboard

Drug Price Trends for OSELTAMIVIR

Average Pharmacy Cost for OSELTAMIVIR

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
OSELTAMIVIR 6 MG/ML SUSPENSION 47781-0384-26 1.34678 ML 2018-11-21
OSELTAMIVIR PHOS 75 MG CAPSULE 70710-1010-02 6.02396 EA 2018-11-21
OSELTAMIVIR 6 MG/ML SUSPENSION 68180-0678-01 1.34678 ML 2018-11-21
Drug Name NDC Price/Unit ($) Unit Date

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Best Wholesale Price for OSELTAMIVIR

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
OSELTAMIVIR PO4 30MG CAP AvKare, Inc. 69238-1264-01 10 75.57 7.55700 EA 2018-10-30 - 2022-12-31 FSS
OSELTAMIVIR PO4 75MG CAP AvKare, Inc. 69238-1266-01 10 82.37 8.23700 EA 2018-10-30 - 2022-12-31 FSS
TAMIFLU CAPSULES 30MG Genentech USA 00004-0802-85 10 132.35 13.23500 EA 2018-01-01 - 2021-09-29 FSS
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Federal Trade Commission
McKinsey
Cipla
Johnson and Johnson
Harvard Business School
Cerilliant
Medtronic
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.